Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.
Blum JL, Dees EC, Chacko A, Doane L, Ethirajan S, Hopkins J, McMahon R, Merten S, Negron A, Neubauer M, Ilegbodu D, Boehm KA, Asmar L, O'Shaughnessy JA.
Blum JL, et al. Among authors: ilegbodu d.
J Clin Oncol. 2006 Sep 20;24(27):4384-90. doi: 10.1200/JCO.2005.05.1383. Epub 2006 Aug 22.
J Clin Oncol. 2006.
PMID: 16926223
Clinical Trial.